jamunjar-logo
whatsapp
cartmembermenu
Search for
"test & packages"
"physiotherapy"
"heart"
"lungs"
"diabetes"
"kidney"
"liver"
"cancer"
"thyroid"
"bones"
"fever"
"vitamin"
"iron"
"HTN"

Serotonin (5-Hydroxy Tryptamine)

Blood
image

Report in 72Hrs

image

At Home

nofastingrequire

No Fasting Required

Details

Serum serotonin measurement.

5,1807,400

30% OFF

Serotonin (5-Hydroxy Tryptamine) Test Information Guide

  • Why is it done?
    • Measures circulating serotonin levels in blood plasma or serum to assess neurotransmitter status and metabolic function
    • Diagnose carcinoid syndrome when elevated urinary 5-hydroxyindoleacetic acid (5-HIAA) is detected, indicating possible carcinoid or neuroendocrine tumors
    • Evaluate suspected neuroendocrine tumors, particularly serotonin-secreting carcinoid tumors of the gastrointestinal tract or lungs
    • Assess for medullary thyroid carcinoma and other serotonin-producing malignancies
    • Investigate symptoms of carcinoid syndrome including flushing, diarrhea, wheezing, and heart palpitations
    • Monitor treatment response in patients with known neuroendocrine tumors or carcinoid disease
    • Typically performed when clinical symptoms suggest carcinoid syndrome or when imaging studies reveal suspicious neuroendocrine lesions
  • Normal Range
    • Standard Reference Range: 50-200 ng/mL (or 0.2-1.0 µmol/L), with specific ranges varying by laboratory method
    • Units of Measurement: Nanograms per milliliter (ng/mL) or micromoles per liter (µmol/L)
    • Normal Result (Negative): Serotonin levels within laboratory reference range indicate normal serotonin metabolism and make carcinoid syndrome or active neuroendocrine tumors less likely
    • Elevated Result (Positive/Abnormal): Serotonin >200 ng/mL suggests possible neuroendocrine tumor or carcinoid syndrome, particularly if accompanied by elevated 5-HIAA in 24-hour urine collection
    • Borderline Values: Results in the 180-220 ng/mL range may warrant repeat testing or additional investigations to confirm findings
    • Important Note: Approximately 5% of healthy individuals may have slightly elevated serotonin levels; clinical interpretation must integrate symptomatology and other test results
  • Interpretation
    • Markedly Elevated Levels (>300 ng/mL): Strongly suggests active carcinoid syndrome or serotonin-secreting neuroendocrine tumor; recommend additional imaging studies (CT/MRI) and chromogranin A testing
    • Moderately Elevated Levels (200-300 ng/mL): Suggestive of possible neuroendocrine tumor; correlate with 24-hour urine 5-HIAA levels and clinical symptoms for diagnostic confirmation
    • Mildly Elevated Levels (150-200 ng/mL): May indicate early-stage disease or benign elevation; requires clinical correlation and possibly repeat testing to establish trend
    • Normal Range (50-200 ng/mL): Reduces probability of active carcinoid syndrome; if symptoms persist, investigate alternative diagnoses or repeat testing after appropriate preparation
    • Low/Undetectable Levels (<50 ng/mL): Effectively excludes carcinoid syndrome; may suggest alternative etiologies for presenting symptoms
    • Factors Affecting Interpretation: Diet (foods high in serotonin: bananas, nuts, chocolate), medications (SSRIs, TCAs, MAO inhibitors), stress levels, platelet aggregation, hemolysis during collection, and timing of blood draw affect results
    • Clinical Correlation Essential: Serotonin alone is insufficient for diagnosis; must be combined with symptoms, imaging, chromogranin A levels, and 5-HIAA to make definitive clinical diagnosis
  • Associated Organs
    • Primary Organ Systems:
    • Gastrointestinal tract (small intestine, colon) - primary site for carcinoid tumors
    • Neuroendocrine system - enterochromaffin cells produce serotonin
    • Lungs - bronchial carcinoid tumors may secrete serotonin
    • Pancreas - pancreatic neuroendocrine tumors may secrete serotonin
    • Thyroid - medullary thyroid carcinoma may produce serotonin
    • Central nervous system - regulates serotonin synthesis and metabolism
    • Cardiovascular system - affected by excessive serotonin leading to carcinoid heart disease
    • Diseases and Conditions Associated with Abnormal Results:
    • Carcinoid syndrome - complex of symptoms caused by excessive serotonin from neuroendocrine tumors
    • Carcinoid tumors - neuroendocrine neoplasms originating from enterochromaffin cells
    • Neuroendocrine tumors (NETs) - various malignancies producing serotonin
    • Medullary thyroid carcinoma - serotonin-producing thyroid malignancy
    • Carcinoid heart disease - valvular fibrosis from chronic serotonin exposure
    • Foregut carcinoids - serotonin-secreting tumors from stomach, pancreas, or lungs
    • Midgut carcinoids - most common type of serotonin-secreting carcinoid tumors
    • Complications Associated with Abnormal Results:
    • Carcinoid heart disease with tricuspid and pulmonary valve involvement
    • Acute carcinoid crisis - severe hypertension and bronchospasm during tumor manipulation
    • Mesenteric fibrosis - ischemic complications from tumor metastases
    • Pulmonary hypertension - from chronic serotonin exposure
    • Malabsorption and nutritional deficiencies - tryptophan diverted to serotonin synthesis
    • Bowel obstruction - from metastatic disease or fibrosis
  • Follow-up Tests
    • Recommended Follow-up Tests if Elevated:
    • 24-hour urine 5-hydroxyindoleacetic acid (5-HIAA) - gold standard for carcinoid syndrome diagnosis; should exceed 8 mg/24 hours to confirm
    • Plasma chromogranin A (CgA) - general neuroendocrine tumor marker; typically elevated in carcinoid disease
    • Chromogranin B and pancreastatin - alternative neuroendocrine markers for tumor burden assessment
    • Neurokinin A levels - often elevated in carcinoid syndrome, particularly midgut tumors
    • CT or MRI imaging - to localize primary tumor and identify metastatic disease
    • Somatostatin receptor scintigraphy (octreoscan) - nuclear imaging to detect somatostatin receptor-positive neuroendocrine tumors
    • PET imaging with 68Ga-DOTATATE - superior sensitivity for detecting neuroendocrine tumors and metastases
    • Upper and lower endoscopy - direct visualization to identify source of tumor
    • Electrocardiography and echocardiography - evaluate for carcinoid heart disease and valvular changes
    • Repeat Testing Frequency:
    • Initial diagnosis - repeat serotonin test after patient dietary and medication preparation to confirm results
    • Confirmed disease - monitor every 3-6 months or per oncology recommendation
    • Post-treatment - serially measure to assess therapeutic response and detect recurrence
    • Stable disease - may retest annually or as clinically indicated
  • Fasting Required?
    • Fasting Status: NO - Fasting is not typically required for serotonin testing
    • Special Dietary Preparation (Strongly Recommended): Follow serotonin-restricted diet for 3-5 days prior to blood collection
    • Foods to Avoid Before Testing:
    • Bananas and plantains - extremely high in serotonin and 5-HT metabolites
    • Pineapple and kiwi - significant serotonin content
    • Nuts and seeds - walnuts, almonds, cashews, sunflower seeds
    • Chocolate and cocoa products - moderate serotonin levels
    • Tomatoes and tomato products - moderate serotonin and tryptophan
    • Avocados - moderate serotonin content
    • Plums, prunes, and plantains
    • Medications to Discontinue or Avoid (3-5 days before test if possible):
    • Selective serotonin reuptake inhibitors (SSRIs) - sertraline, paroxetine, fluoxetine, citalopram
    • Tricyclic antidepressants (TCAs) - amitriptyline, nortriptyline, imipramine
    • Monoamine oxidase inhibitors (MAOIs) - phenelzine, tranylcypromine, isocarboxazid
    • Amphetamines and sympathomimetics - elevate serotonin levels
    • Lithium - affects serotonin metabolism
    • Levodopa and bromocriptine - can affect serotonin levels
    • Other Patient Preparation Requirements:
    • Rest and stress reduction - avoid strenuous exercise for 24 hours prior to test; mental stress affects serotonin levels
    • Morning blood draw preferred - collect sample between 8-10 AM when possible
    • Avoid excessive alcohol consumption - can interfere with serotonin metabolism
    • Special sample handling - blood must be collected in appropriate tube, kept cool, and processed promptly to prevent false elevation from platelet breakdown
    • Avoid tryptophan supplementation - discontinue at least one week before testing
    • Consult with laboratory and physician - specific preparation protocols may vary by institution and clinical context

How our test process works!

customers
customers